Pfizer Inc.
PFE
$25.06
-$0.73-2.83%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.67% | -- | -4.75% | 112.17% | 287.45% |
| Total Depreciation and Amortization | -5.09% | -- | -6.81% | 7.32% | 12.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -48.81% | -- | 22.33% | 205.97% | -106.88% |
| Change in Net Operating Assets | -104.10% | -- | 42.48% | -65.37% | 173.31% |
| Cash from Operations | -31.44% | -- | 114.22% | 28.26% | 94.27% |
| Capital Expenditure | 7.53% | -- | 19.89% | 12.16% | 19.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -30.01% | -- | 57.55% | -102.11% | -182.80% |
| Cash from Investing | -18.13% | -- | 89.03% | 85.24% | -331.64% |
| Total Debt Issued | -100.00% | -- | -- | -90.46% | 9,922.73% |
| Total Debt Repaid | 100.14% | -- | 32.71% | -3,451.46% | -213.73% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.69% | -- | -2.74% | -2.81% | -2.85% |
| Other Financing Activities | -550.00% | -- | 7.77% | 22.22% | 83.78% |
| Cash from Financing | 46.57% | -- | -6.00% | -193.97% | -22.68% |
| Foreign Exchange rate Adjustments | -77.78% | -- | 75.00% | -2,800.00% | 128.13% |
| Miscellaneous Cash Flow Adjustments | 300.00% | -- | -- | -- | -150.00% |
| Net Change in Cash | -1,134.48% | -- | 117.50% | 85.71% | -94.58% |